Livorno

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Lung cancer1 trial
• Sarcoma1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials

Lead sponsor

• AstraZeneca3 trials

Running trials

• Active, not recruiting

  Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

  NCT04784715· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer

  NCT04494425· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

  NCT01933932· Phase 3· AstraZeneca· Source